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Recent genetic analyses have indicated that polymor-
phisms in the mouse APOBEC3 locus constitute the Rfv3
gene that influences the production of virus-neutralizing
antibodies in mice infected with Friend leukemia retrovi-
rus [1,2]. Mice of the resistant genotype preferentially
express the exon 5-lacking transcript in higher levels,
while susceptible mice express the full-length transcript in
lower levels [2,3]. Mouse APOBEC3 expressed in the
resistant strains restricts the replication of mouse retrovi-
ruses in vitro through a mechanism independent of its
deaminase activity [2]. However, the mechanisms
through which mouse APOBEC3 affects the production of
virus-neutralizing antibodies remain unclear. To address
this question, we analyzed retroviral replication and the
production of virus-neutralizing antibodies in mice of dif-
ferent APOBEC3 genotypes and those lacking its expres-
sion.
Strain A mice with the susceptible APOBEC3  genotype
nevertheless produced high levels of virus-neutralizing
antibodies when they possessed the H-2b haplotype, and
class-switching to IgG was observed in the presence of
virus-specific T helper cells. Further, APOBEC3-deficient
mice produced virus-neutralizing antibodies when their T
helper cells had been primed with the viral antigen. Friend
virus-induced derangements in the hematopoiesis and
resultant splenomegaly are not directly responsible for the
delayed antibody responses, because higher levels of
viremia and lower antibody responses were observed
upon infection with nonpathogenic Friend murine leuke-
mia helper virus in the absence of APOBEC3. In mice of
the resistance-associated APOBEC3 genotype lower levels
of viremia were observed even before the detection of
virus-neutalizing antibodies in the blood, indicating that
the polymorphisms in the APOBEC3 locus affect the pro-
duction of neutralizing antibodies as a result of restricted
retroviral replication.
Conclusion
B cells from the mice of susceptible APOBEC3 genotypes
produce neutralizing antibodies in the presence of virus-
specific T helper cells. Polymorphisms in the APOBEC3
affect the levels of viremia prior to the production of neu-
tralizing antibodies, indicating that APOBEC3 may indi-
rectly influence B cell functions by restricting viral
replication.
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